Stay updated with breaking news from David Bartel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 4,930,000 shares, a decline of 8.5% from the February 28th total of 5,390,000 shares. Based on an average daily volume of 781,100 shares, the days-to-cover ratio is currently 6.3 days. […]
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) have been given an average rating of “Moderate Buy” by the twenty-two research firms that are presently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average […]
Verition Fund Management LLC bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 4,827 shares of the biopharmaceutical company’s stock, valued at approximately $966,000. A number of other hedge funds have also […]
Sherry Nyeo, an MIT senior majoring in computer science and molecular biology, studies RNA and plans to pursue a career in biotechnology. She participates in NEET and MIT Biotech Group and advises students through the Undergraduate Research Opportunities Program (UROP).
